In the recent findings from The Lancet, Tamiflu’s efficiency now counts to lessening flu symptoms to almost 24 hours. This research includes nine unpublished and published randomized clinical tests of Tamiflu as given by its manufacturing company, Roche.
In this case, researchers have made a comparison of a placebo and 75mg dose of Tamiflu in 4,300 adults stricken with flu between 1997 and 2001. Among patients who were affected by flu, the symptoms went away by 21 percent and also lowered the risk of respiratory infections by 44 percent specifically those needing antibiotics and 63 percent for illnesses requiring hospitalizations.